Skip to main content
. Author manuscript; available in PMC: 2021 Jul 1.
Published in final edited form as: J Cardiovasc Nurs. 2020 Jul-Aug;35(4):327–336. doi: 10.1097/JCN.0000000000000646

Table 2.

Mean scores for HRQOL and AF symptom severity at baseline and follow-up (N=238)

Scale Intervention (n=115) Control (n=123)
Baseline Follow-Up Response Baseline Follow-up Response
N M (SD) N M (SD) N M (SD) SRM N M (SD) N M (SD) N M (SD) SRM
Atrial Fibrillation Effect on Quality of Life (AFEQT)
 Global 87 66.3 (21.0) 56 79.0 (20.3) 53 18.5* (25.5) 0.73 79 64.8 (25.2) 55 80.2 (20.9) 53 11.2* (18.5) 0.61
 Symptom 87 72.8 (24.0) 56 82.2 (24.6) 53 15.7* (27.1) 0.58 79 71.8 (27.5) 55 88.3 (16.5) 53 12.2* (23.4) 0.52
 Daily activities 87 64.9 (27.0) 56 78.8 (26.4) 53 20.2* (31.9) 0.63 78 62.2 (31.7) 55 78.0 (28.1 53 12.7* (27.5) 0.46
 Treatment concern 86 64.0 (27.5) 55 76.8 (21.2) 51 18.4* (29.5) 0.62 76 65.0 (24.6) 54 77.9 (24.4) 50 8.8 (22.8) 0.39
 Satisfaction 83 72.8 (23.9) 54 86.3 (20.2) 49 14.5* (27.2) 0.53 73 67.7 (28.3) 51 84.8 (20.3) 45 11.9 (21.1) 0.42
Short-Form Health Survey (SF-36)
 PCS 88 49.6 (8.6) 57 52.5 (9.1) 54 3.0* (5.8) 0.51 79 47.6 (9.5) 56 50.1 (8.5) 53 1.8 (7.4) 0.24
 MCS 88 50.8 (8.5) 57 53.1 (8.6) 54 2.6 (6.9) 0.38 79 48.9 (9.6) 56 52.7 (7.5) 53 3.1 (7.9) 0.40
EuroQol-5D (EQ-5D)
 Index 90 0.88 (0.16) 58 0.94 (0.14) 55 0.03 (0.11) 0.32 85 0.85 (0.21) 56 0.91 (0.13) 55 0.04 (0.19) 0.19
 VAS 93 74.4 (15.8) 60 80.6 (14.6) 59 4.8 (15.7) 0.31 82 74.1 (14.7) 57 77.0 (15.1) 56 0.5 (14.8) 0.03
University of Toronto Atrial Fibrillation Severity Scale (AFSS)
 AFSS score 90 9.5 (7.0) 57 5.2 (7.1) 55 −5.4* (7.2) −0.74 78 11.6 (8.9) 54 5.1 (6.3) 50 −4.5* (8.2) −0.55

Note. SRM= standardized response mean; Response= score at follow-up minus score at baseline.

*

p-value <0.01 for testing response mean score equal to 0 (t-test, p-values were adjusted for multiple tests with Bonferroni correction).